Skip to content

Inspection Record

Baxter Healthcare Corporation — FDA 483 Findings

US FDAInspected 2025-11-25Published 2026-10-30 5 findingsLaboratory and QC controlsTraining and personnelComputer system validationQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.

2Training and personnel

Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.

3Laboratory and QC controls

Laboratory records do not include a description of the sample received for testing, the quantity of the sample and the date the sample was received for testing.

4Computer system validation

Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.

5Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not fully followed.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-30. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Baxter Healthcare Corporation findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.